他点赞了
他点赞了
他点赞了
他点赞了
Cyber Risks and Debt Are Pushing Canada Toward a Critical Inflection Point
From where I sit as an active market participant, the latest CSA 2025 survey feels less like a warning and more like a roadmap of what traders should be preparing for. When 65% of investment professionals openly question the stability of Canada’s financial system, it tells you sentiment is shi
他点赞了
他点赞了
他点赞了
How to Approach Prop Trading Safely: A Beginner’s Practical Guide
Partner Center By now, you know the opportunities and risks of prop firms. You know: What are prop firms are. The promises and the myths. How firms actually make money. Why some are scams and why some aren’t. And that success is possible but rare. But here’s the challenge: How do you approach prop f
他点赞了
他点赞了
他点赞了
What the Fed Chair Choice Could Signal
If the next Fed Chair picks aligns with President Trump’s wishes, we could see signals of faster action on interest rates and perhaps a stronger push toward stimulating growth. Trump has repeatedly criticized Jerome Powell for not cutting rates more quickly and said his term should end sooner.
他点赞了
DexCom (DXCM) Eyes Deeper Correction Toward $44.11–$20.95 Zone
DexCom Inc., (DXCM) is a medical device company, that focuses on the design, development & commercialization of glucose monitoring systems globally. It comes under Healthcare sector & trades as “DXCM” ticker at Nasdaq. The DXCM favors double correction in weekly from November-2021 high discu

正在加载中...

